Anthropic just brought Novartis CEO onto their board today, and as usual, their official press release is filled with phrases like 'long-term human interests' and 'responsible deployment.' Back in February, they brought in former executives from General Motors and Microsoft, and now they've added the current head of a top multinational pharmaceutical company. This is a textbook, powerhouse Pre-IPO lineup, paired with a top-tier executive team targeting heavily regulated industries. Anthropic had already signed deals with Eli Lilly and Novo Nordisk, and now they've directly brought Novartis' Vas Narasimhan to the table—could their intentions be any clearer? Tweeting predictions about when AGI will arrive is easy, but integrating cutting-edge technology into the massive healthcare system in a compliant way to genuinely shorten drug development cycles? That’s where real, tangible value is created.